Armistice Capital, LLC 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase |
2024-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 5,216,445 9.990% |
642,699 (+14.05%) |
Filing |
| 2024-11-14 4:49 pm Purchase |
2024-09-30 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 4,573,746 9.990% |
1,858,111 (+68.42%) |
Filing |
| 2024-02-14 2:24 pm Purchase |
2023-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 2,715,635 9.990% |
1,728,424 (+175.08%) |
Filing |
| 2023-02-14 12:23 pm Purchase |
2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 987,211 9.990% |
987,211 (New Position) |
Filing |